Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Immunoglobulin Light-chain Amyloidosis 1Congenital Abnormalities 1

Interventions

Cytarabine 9Daunorubicin 5Peripheral Blood Stem Cell Transplantation 4Idarubicin 4Etoposide 4Radiotherapy 3Mitoxantrone 3Filgrastim 3Cyclophosphamide 3lintuzumab 2Microarray Analysis 2Busulfan 2sargramostim 1midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1aldesleukin 1Tretinoin 1Thioguanine 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Mesna 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1Everolimus 1DNA Methylation 1Clofarabine 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelomonocytic, Acute × dexamethasone acetate × Clear all
NCT00651261 2021-08-18

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
717 enrolled 14 charts
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡